Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.

Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Atherosclerosis. 2020 Jan 9. pii: S0021-9150(19)31623-5. doi: 10.1016/j.atherosclerosis.2019.12.005. [Epub ahead of print] Review.

PMID:
31928713
2.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem Lab Med. 2019 Dec 19. pii: /j/cclm.ahead-of-print/cclm-2019-1253/cclm-2019-1253.xml. doi: 10.1515/cclm-2019-1253. [Epub ahead of print]

PMID:
31855562
3.

Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress.

Turunen TA, Roberts TC, Laitinen P, Väänänen MA, Korhonen P, Malm T, Ylä-Herttuala S, Turunen MP.

Sci Rep. 2019 Jul 17;9(1):10332. doi: 10.1038/s41598-019-46841-1.

4.

Activating the Chromatin by Noncoding RNAs.

Laham-Karam N, Laitinen P, Turunen TA, Ylä-Herttuala S.

Antioxid Redox Signal. 2018 Sep 20;29(9):813-831. doi: 10.1089/ars.2017.7248. Epub 2017 Aug 10. Review.

PMID:
28699365
5.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

6.

First-trimester maternal serum ADAM12-s and PAPP-A levels are altered in pregnancies conceived after assisted reproduction techniques (ART).

Sahraravand M, Laitinen P, Järvelä I, Ryynänen M.

Prenat Diagn. 2016 Feb;36(2):163-9. doi: 10.1002/pd.4764. Epub 2016 Jan 26.

PMID:
26697810
7.

Combined first-trimester screening in northern Finland: experiences of the first ten years.

Merilainen A, Peuhkurinen S, Honkasalo T, Laitinen P, Kokkonen H, Ryynanen M, Marttala J.

Clin Med Insights Reprod Health. 2014 Jul 30;8:45-9. doi: 10.4137/CMRH.S14958. eCollection 2014.

8.

Extremely large nuchal translucency measurement predicts adverse pregnancy outcome.

Pitkanen S, Laitinen P, Yla-Outinen A, Heikkila M, Honkasalo T, Ryynanen M, Marttala J.

J Obstet Gynaecol. 2015 Jan;35(1):22-4. doi: 10.3109/01443615.2014.935713. Epub 2014 Jul 14.

PMID:
25020113
9.

Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference.

Savukoski T, Jacobino J, Laitinen P, Lindahl B, Venge P, Ristiniemi N, Wittfooth S, Pettersson K.

Clin Chem Lab Med. 2014 Jul;52(7):1041-8. doi: 10.1515/cclm-2013-1044.

PMID:
24615485
10.

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group.

Langlois MR, Descamps OS, van der Laarse A, Weykamp C, Baum H, Pulkki K, von Eckardstein A, De Bacquer D, Borén J, Wiklund O, Laitinen P, Oosterhuis WP, Cobbaert C; EAS-EFLM Collaborative Project.

Atherosclerosis. 2014 Mar;233(1):83-90. doi: 10.1016/j.atherosclerosis.2013.12.016. Epub 2014 Jan 4.

PMID:
24529127
11.

Extension of dynamic range of sensitive nanoparticle-based immunoassays.

Hyytiä H, Ristiniemi N, Laitinen P, Lövgren T, Pettersson K.

Anal Biochem. 2014 Feb 1;446:82-6. doi: 10.1016/j.ab.2013.10.034. Epub 2013 Nov 6.

PMID:
24211398
12.
13.

Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland.

Peuhkurinen S, Laitinen P, Honkasalo T, Ryynanen M, Marttala J.

Acta Obstet Gynecol Scand. 2013 Jul;92(7):769-74. doi: 10.1111/aogs.12095. Epub 2013 Apr 9.

PMID:
23369035
14.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).

Hammerer-Lercher A, Collinson P, van Dieijen-Visser MP, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem Lab Med. 2013 Jun;51(6):1301-6. doi: 10.1515/cclm-2012-0510.

PMID:
23334056
15.

Comparison of automated 25-OH vitamin D immunoassays with liquid chromatography isotope dilution tandem mass spectrometry.

Koivula MK, Turpeinen U, Laitinen P, Risteli J.

Clin Lab. 2012;58(11-12):1253-61.

PMID:
23289196
16.

Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation.

Aakre KM, Langlois MR, Watine J, Barth JH, Baum H, Collinson P, Laitinen P, Oosterhuis WP.

Clin Chem Lab Med. 2013 Jun;51(6):1217-26. Review.

PMID:
23037517
18.

First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age.

Peuhkurinen S, Laitinen P, Ryynanen M, Marttala J.

J Eval Clin Pract. 2013 Apr;19(2):324-6. doi: 10.1111/j.1365-2753.2012.01826.x. Epub 2012 Mar 27.

PMID:
22458815
19.

Effect of parity and fetal sex on placental and luteal hormones during early first trimester.

Järvelä IY, Záčková T, Laitinen P, Ryynänen M, Tekay A.

Prenat Diagn. 2012 Feb;32(2):160-7. doi: 10.1002/pd.2921.

PMID:
22418960
20.

Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening.

Valinen Y, Marttala J, Sahravand M, Jarvela I, Honkasalo T, Laitinen P, Ryynanen M.

J Matern Fetal Neonatal Med. 2012 Jun;25(6):822-5. doi: 10.3109/14767058.2011.590559. Epub 2012 Feb 6.

PMID:
22309076
21.

First trimester biochemistry at different maternal ages.

Ranta JK, Marttala J, Laitinen P, Kultti J, Kauhanen O, Romppanen J, Hämäläinen E, Heinonen S, Pulkki K, Ryynänen M.

Clin Chem Lab Med. 2011 Nov 24;50(3):549-55. doi: 10.1515/CCLM.2011.785.

PMID:
22112052
22.

The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy.

Sahraravand M, Järvelä IY, Laitinen P, Tekay AH, Ryynänen M.

Placenta. 2011 Dec;32(12):999-1003. doi: 10.1016/j.placenta.2011.10.005. Epub 2011 Oct 19.

PMID:
22015022
23.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

24.

False-negative results in routine combined first-trimester screening for down syndrome in Finland.

Marttala J, Kaijomaa M, Ranta J, Dahlbacka A, Nieminen P, Tekay A, Kokkonen H, Laitinen P, Ignatius J, Romppanen J, Heinonen S, Jarvela I, Heikkila M, Yla-Outinen A, Ulander VM, Hamalainen E, Ryynanen M.

Am J Perinatol. 2012 Mar;29(3):211-6. doi: 10.1055/s-0031-1285095. Epub 2011 Aug 10.

PMID:
21833895
25.

Screening and outcome of chromosomal abnormalities other than trisomy 21 in Northern Finland.

Marttala J, Peuhkurinen S, Ranta JK, Laitinen P, Kokkonen HL, Honkasalo T, Ryynanen M.

Acta Obstet Gynecol Scand. 2011 Aug;90(8):885-9. doi: 10.1111/j.1600-0412.2011.01174.x. Epub 2011 Jun 14.

PMID:
21539522
26.

Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group on Creatinine Standardization.

Delanghe JR, Cobbaert C, Harmoinen A, Jansen R, Laitinen P, Panteghini M.

Clin Chem Lab Med. 2011 Jun;49(6):977-82. doi: 10.1515/CCLM.2011.167. Epub 2011 Mar 24.

PMID:
21428858
27.

More invasive procedures are done to detect each case of Down's syndrome in younger women.

Marttala J, Ranta JK, Kaijomaa M, Nieminen P, Laitinen P, Kokkonen H, Romppanen J, Hamalainen E, Kultti J, Tekay A, Ulander VM, Honkasalo T, Ryynanen M.

Acta Obstet Gynecol Scand. 2011 Jun;90(6):642-7. doi: 10.1111/j.1600-0412.2011.01113.x. Epub 2011 Apr 15.

PMID:
21355862
28.

Association of ADAM12-S protein with radiographic features of knee osteoarthritis and bone and cartilage markers.

Kerna I, Kisand K, Laitinen P, Tamm AE, Kumm J, Lintrop M, Tamm AO.

Rheumatol Int. 2012 Feb;32(2):519-23. doi: 10.1007/s00296-010-1717-6. Epub 2011 Jan 22.

PMID:
21258805
29.

In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies.

Matilainen M, Peuhkurinen S, Laitinen P, Jarvela I, Morin-Papunen L, Ryynanen M.

Fertil Steril. 2011 Jan;95(1):378-81. doi: 10.1016/j.fertnstert.2010.07.1048. Epub 2010 Aug 19.

PMID:
20723891
30.

Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths.

Marttala J, Peuhkurinen S, Laitinen P, Gissler M, Nieminen P, Ryynanen M.

Acta Obstet Gynecol Scand. 2010 Sep;89(9):1226-8. doi: 10.3109/00016349.2010.493195.

PMID:
20590503
31.

Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.

Valinen Y, Peuhkurinen S, Järvelä IY, Laitinen P, Ryynanen M.

Gynecol Obstet Invest. 2010;70(1):60-3. doi: 10.1159/000289178. Epub 2010 Feb 27.

PMID:
20197665
32.

Laboratory and quality regulations and accreditation standards in Finland.

Laitinen P.

Clin Biochem. 2009 Mar;42(4-5):312-3. doi: 10.1016/j.clinbiochem.2008.09.033. No abstract available.

PMID:
19863939
33.

Effect of a new marker, ADAM12, on Down risk figures in first trimester screening.

Valinen Y, Laitinen P, Ranta J, Ignatius J, Jarvela I, Ryynänen M.

J Matern Fetal Neonatal Med. 2009 Jul;22(7):602-7. doi: 10.1080/14767050902755478.

PMID:
19736612
34.

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen P.

Clin Chem Lab Med. 2009;47(2):227-34. doi: 10.1515/CCLM.2009.044.

PMID:
19099527
35.

Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group.

Delanghe JR, Cobbaert C, Galteau MM, Harmoinen A, Jansen R, Kruse R, Laitinen P, Thienpont LM, Wuyts B, Weykamp C, Panteghini M.

Clin Chem Lab Med. 2008;46(9):1319-25. doi: 10.1515/CCLM.2008.256.

PMID:
18605952
36.

Effects of soil phosphorus status on environmental risk assessment of glyphosate and glufosinate-ammonium.

Laitinen P, Siimes K, Rämö S, Jauhiainen L, Eronen L, Oinonen S, Hartikainen H.

J Environ Qual. 2008 May 2;37(3):830-8. doi: 10.2134/jeq2007.0256. Print 2008 May-Jun.

PMID:
18453404
37.

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

Collinson P, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen PH.

Clin Chem. 2008 Feb;54(2):448-9. doi: 10.1373/clinchem.2007.097501. No abstract available.

38.

Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.

Valinen Y, Rapakko K, Kokkonen H, Laitinen P, Tekay A, Ahola T, Ryynanen M.

Am J Obstet Gynecol. 2007 Mar;196(3):278.e1-5.

PMID:
17346554
39.

Designing web services in health information systems: from process to application level.

Mykkänen J, Riekkinen A, Sormunen M, Karhunen H, Laitinen P.

Int J Med Inform. 2007 Feb-Mar;76(2-3):89-95. Epub 2006 Nov 22.

PMID:
17118700
40.

Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.

Paavonen KJ, Swan H, Piippo K, Laitinen P, Fodstad H, Sarna S, Toivonen L, Kontula K, Viitasalo M.

Int J Cardiol. 2007 May 31;118(2):197-202. Epub 2006 Oct 4.

PMID:
17023080
41.

Fate of the herbicides glyphosate, glufosinate-ammonium, phenmedipham, ethofumesate and metamitron in two Finnish arable soils.

Laitinen P, Siimes K, Eronen L, Rämö S, Welling L, Oinonen S, Mattsoff L, Ruohonen-Lehto M.

Pest Manag Sci. 2006 Jun;62(6):473-91.

PMID:
16628542
42.

Designing web services in health information systems: from process to application level.

Mykkänen J, Riekkinen A, Laitinen P, Karhunen H, Sormunen M.

Stud Health Technol Inform. 2005;116:515-20.

PMID:
16160309
43.

End-to-end Encryption for SMS Messages in the Health Care Domain.

Hassinen M, Laitinen P.

Stud Health Technol Inform. 2005;116:316-21.

PMID:
16160278
44.

A guide to defining the competence required of a consultant in clinical chemistry and laboratory medicine.

Beastall G, Kenny D, Laitinen P, ten Kate J.

Clin Chem Lab Med. 2005;43(6):654-9.

PMID:
16006263
45.

Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.

Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H.

Cardiovasc Res. 2005 Aug 15;67(3):379-87. Review.

PMID:
15913575
46.
47.

Temporal repolarization lability differences among genotyped patients with the long QT syndrome.

Bilchick K, Viitasalo M, Oikarinen L, Fetics B, Tomaselli G, Swan H, Laitinen PJ, Väänänen H, Kontula K, Berger RD.

Am J Cardiol. 2004 Nov 15;94(10):1312-6.

PMID:
15541256
48.

Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.

Swan H, Laitinen PJ, Toivonen L.

Anesth Analg. 2004 Aug;99(2):435-7, table of contents.

PMID:
15271719
49.

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.

Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR.

Circulation. 2004 Jun 29;109(25):3208-14. Epub 2004 Jun 14.

PMID:
15197150
50.

Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.

Laitinen PJ, Swan H, Piippo K, Viitasalo M, Toivonen L, Kontula K.

Ann Med. 2004;36 Suppl 1:81-6. Review.

PMID:
15176428

Supplemental Content

Loading ...
Support Center